CINECA IRIS Institutional Research Information System

TRINCAVELLI, MARIA LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.051
AS - Asia 10.099
EU - Europa 8.532
SA - Sud America 1.254
Continente sconosciuto - Info sul continente non disponibili 496
AF - Africa 449
OC - Oceania 30
Totale 42.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.378
IT - Italia 3.300
SG - Singapore 3.046
CN - Cina 2.806
HK - Hong Kong 1.479
SE - Svezia 1.157
VN - Vietnam 1.098
BR - Brasile 1.050
DE - Germania 825
BG - Bulgaria 653
CA - Canada 528
TR - Turchia 515
GB - Regno Unito 463
FR - Francia 415
FI - Finlandia 382
RU - Federazione Russa 307
UA - Ucraina 277
AT - Austria 247
IN - India 232
JP - Giappone 216
KR - Corea 204
CH - Svizzera 107
NG - Nigeria 98
SN - Senegal 91
CI - Costa d'Avorio 90
NL - Olanda 81
MX - Messico 73
IQ - Iraq 70
BD - Bangladesh 68
BE - Belgio 64
AR - Argentina 60
PL - Polonia 55
PK - Pakistan 53
ID - Indonesia 47
ZA - Sudafrica 47
EE - Estonia 39
ES - Italia 35
EC - Ecuador 30
IR - Iran 29
AU - Australia 28
UZ - Uzbekistan 28
CO - Colombia 26
VE - Venezuela 26
MA - Marocco 23
MY - Malesia 23
SA - Arabia Saudita 22
GR - Grecia 20
KE - Kenya 20
EG - Egitto 19
JO - Giordania 19
JM - Giamaica 17
AE - Emirati Arabi Uniti 16
PH - Filippine 16
PY - Paraguay 15
IL - Israele 14
AZ - Azerbaigian 13
PE - Perù 13
PT - Portogallo 13
UY - Uruguay 13
BJ - Benin 12
NP - Nepal 12
RO - Romania 12
CZ - Repubblica Ceca 11
LT - Lituania 11
CL - Cile 10
CR - Costa Rica 10
DZ - Algeria 10
IE - Irlanda 10
TT - Trinidad e Tobago 10
TN - Tunisia 9
TW - Taiwan 9
ET - Etiopia 8
KZ - Kazakistan 8
BO - Bolivia 7
GE - Georgia 7
AL - Albania 6
BH - Bahrain 6
PS - Palestinian Territory 6
RS - Serbia 6
HN - Honduras 5
KG - Kirghizistan 5
OM - Oman 5
PA - Panama 5
BF - Burkina Faso 4
BN - Brunei Darussalam 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HR - Croazia 4
LB - Libano 4
PR - Porto Rico 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
HU - Ungheria 3
KW - Kuwait 3
MD - Moldavia 3
ML - Mali 3
NI - Nicaragua 3
QA - Qatar 3
Totale 42.359
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.115
Ashburn 2.085
Ann Arbor 1.899
Singapore 1.636
Houston 1.605
Hong Kong 1.450
Chandler 1.274
Fairfield 1.269
San Jose 1.011
Serra 994
Dallas 949
Santa Clara 904
Sofia 649
Milan 643
Shanghai 637
Beijing 592
Seattle 541
Wilmington 466
New York 447
Cambridge 427
Ottawa 410
Boardman 340
Los Angeles 313
Princeton 305
Jacksonville 304
Izmir 294
Council Bluffs 292
Ho Chi Minh City 251
Lawrence 244
Dong Ket 242
Lauterbourg 222
Medford 218
Hefei 208
Vienna 208
Nanjing 203
Tokyo 200
Hanoi 176
Seoul 174
Des Moines 172
Pisa 149
Istanbul 133
Dearborn 126
Florence 115
Frankfurt am Main 113
London 113
Helsinki 110
Buffalo 99
Chicago 97
Lagos 96
The Dalles 94
Columbus 92
Redondo Beach 92
Dakar 91
Abidjan 90
Rome 88
Munich 84
Nanchang 84
São Paulo 81
Redwood City 80
Lucca 70
Bern 68
San Diego 67
Brussels 64
Falls Church 61
Bremen 56
Lancaster 55
Kunming 54
Jüchen 48
Shenyang 48
Guangzhou 46
Orem 46
Da Nang 43
Ogden 43
Warsaw 43
Changsha 42
Rio de Janeiro 41
Turku 41
Boulder 40
Phoenix 40
Pune 40
Tianjin 40
Washington 40
Alessandria 38
Rho 38
Tallinn 38
Nuremberg 36
Amsterdam 34
Toronto 34
Atlanta 33
Livorno 33
Montreal 33
Hebei 31
Düsseldorf 30
Kent 30
Belo Horizonte 29
Chennai 29
Marseille 29
Brooklyn 28
San Francisco 28
Auburn Hills 27
Totale 30.110
Salva come PNG Salva come JPEG
Nome #
Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region 552
METODO PER LA DIAGNOSI DI MALATTIE NEURODEGENERATIVE 342
G PROTEIN-COUPLED RECEPTOR DESENSITISATION REGULATES STEM CELL DIFFERENTIATION 338
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 331
18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile 319
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 310
Synthesis and 3D QSAR of New Pyrazolo[3,4-b]pyridines: Potent and Selective Inhibitors of A1 Adenosine Receptors 277
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 277
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 276
A (2A) ADENOSINE RECEPTOR LIGANDS AND PROINFLAMMATORY CYTOKINES INDUCE PC12 CELL DEATH THROUGH APOPTOSIS 271
Force induces axon growth in inhibitory conditions 270
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 269
New insights into the anticancer activity of carnosol: P53 reactivation in the U87MG human glioblastoma cell line 268
Phytochemical analysis and antisenescence activity of Sorbus torminalis (L.) Crantz and Elaeagnus umbellata Thunb fruits 263
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 258
A2A adenosine receptor binding parameters in platelets from patients affected by pathological gambling 249
Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder 243
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 237
Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals 236
Allosteric modulators of human A2B adenosine receptor. 235
Effect of Ribes nigrum bud extract on human gingival mesenchymal stem cell cytokine release: a role on regenerative processes 235
1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists 234
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 232
1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists 231
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 225
Redefining platinum(IV) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapies 223
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 221
Carnosol controls the human glioblastoma stemness features through the epithelial-mesenchymal transition modulation and the induction of cancer stem cell apoptosis 218
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 217
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 215
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent 213
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 213
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 210
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. 208
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 208
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death 208
Synthesis and AT1 affinity evaluation of benzamidophenyl analogs of known AT1 receptor ligands with similar aromatic skeleton 207
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 203
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies. 203
Epigenetic Modifications of the α-Synuclein Gene and Relative Protein Content Are Affected by Ageing and Physical Exercise in Blood from Healthy Subjects 202
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 200
The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization 200
Synthesis and antihypertensive action of new Imidazo[1,2-a]pyridine derivatives, non peptidic Angiotensin II receptor antagonists 199
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 199
A1 Adenosine receptors in Human neutrophils: electron microscope localization 197
A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation. 197
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 196
Antioxidant activity of compounds isolated from Elaeagnus umbellata promotes human gingival fibroblast well-being 196
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 196
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives 195
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 195
Negative effects of a high tumour necrosis factor-α concentration on human gingival mesenchymal stem cell trophism: The use of natural compounds as modulatory agents 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation 192
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 192
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 192
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 188
The A2B adenosine receptor modulates the epithelial- mesenchymal transition through the balance of cAMP/PKA and MAPK/ERK pathway activation in human epithelial lung cells 188
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer 188
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 187
Multimaterial and multiscale scaffold for engineering enthesis organ 186
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 186
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 184
Adenosine receptors: what we know and what we are learning 184
Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists 184
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 184
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 180
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 180
Benzodiazepine receptos in porcine pancreatic islets 179
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways? 179
Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization 178
The oral reversibly-binding antiplatelet agent, Ticagrelor, acts as an antagonist at the P2Y-like receptor GPR17 178
Livelli di citochine e cortisolo ematici in pazienti affetti da disturbo post-traumatico da stress (PTSD) e lutto complicato 177
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 175
The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets 174
A1 AND A2B ADENOSINE RECEPTORS REGULATE GLIOBLASTOMA STEM CELL DIFFERENTIATION/SURVIVAL AND SENSITIZE CELLS TO CHEMOTHERAPY 174
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 173
Cornus sanguinea Fruits: a Source of Antioxidant and Antisenescence Compounds Acting on Aged Human Dermal and Gingival Fibroblasts 173
Peripheral-type benzodiazepine receptor and steroid serum levels in civilian population with post-traumatic stress disorder 171
A1 adenosine receptors in human neutrophils. Electron microscope localization 169
Copper (II) ions modulate Angiogenin activity in human endothelial cells 169
Inflammation and neurodegeneration plasmatic biomarkers in patients with obstructive sleep apnea syndrome and mild cognitive impairment 168
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 168
Lifetime manic-hypomanic symptoms in post-traumatic stress disorder: relationship with the 18 kDa mitochondrial translocator protein density. 168
Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands 168
A rapid and efficient immunoenzymatic assay to detect receptor protein interactions: g protein-coupled receptors. 168
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 168
TUMOR NECROSIS FACTOR ALPHA TRIGGERS OSTEOGENESIS THROUGH THE INVOVLVEMENT OF Gs-COUPLED RECEPTOR SIGNALS 167
Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells 166
Drug Mechanism: A bioinformatic update 165
Correlation between lymphocytic peripheral benzodiazepine receptor levels and psychiatric scale scorse in post-traumatic stress disorder and traumatic grief 164
Substituted Pyrazolo3,4-bpyridines as Potent A1 Adenosine Antagonists: Synthesis, Biological Evaluation, and Development of an A1 Bovine Receptor Model 164
2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists 164
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights 164
Functional interaction between A1 and P2Y1 purinergic receptors in the brain 163
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 163
Correlations between anxiety spectrum assessments and saliva cortisol changes in post-traumatic stress disorder and traumatic grief 162
The effect of noise exposure on peripheralbenzodiazepine receptors in rat heart 161
Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls 161
Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists 161
Totale 20.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.842 0 239 78 148 509 399 85 159 104 101 172 848
2022/20234.000 510 502 241 435 481 543 51 266 649 30 197 95
2023/20242.898 338 315 391 202 425 467 121 91 50 63 108 327
2024/20258.063 49 340 130 526 741 764 647 465 874 1.086 803 1.638
2025/20269.167 507 1.123 1.046 703 898 865 1.665 389 521 751 425 274
2026/20271.110 646 464 0 0 0 0 0 0 0 0 0 0
Totale 42.911